Beaumont Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,517
Closed -$444K 74
2025
Q1
$444K Buy
17,517
+528
+3% +$13.8K 0.27% 54
2024
Q4
$451K Buy
16,989
+209
+1% +$5.67K 0.26% 50
2024
Q3
$486K Sell
16,780
-70
-0.4% -$2.04K 0.28% 47
2024
Q2
$471K Buy
+16,850
New +$464K 0.3% 49
2024
Q1
Sell
-25,465
Closed -$733K 67
2023
Q4
$733K Sell
25,465
-994
-4% -$30K 0.52% 41
2023
Q3
$878K Sell
26,459
-113
-0.4% -$4K 0.72% 29
2023
Q2
$975K Sell
26,572
-754
-3% -$29.3K 0.74% 33
2023
Q1
$1.11M Sell
27,326
-1,824
-6% -$78.8K 0.82% 27
2022
Q4
$1.49M Buy
29,150
+325
+1% +$15.6K 1.09% 22
2022
Q3
$1.26M Buy
28,825
+269
+0.9% +$13.1K 1% 22
2022
Q2
$1.5M Buy
28,556
+2,935
+11% +$150K 1.13% 20
2022
Q1
$1.33M Sell
25,621
-478
-2% -$24.8K 0.9% 23
2021
Q4
$1.54M Buy
26,099
+566
+2% +$28K 1.03% 19
2021
Q3
$1.1M Buy
25,533
+1,849
+8% +$81.9K 0.82% 22
2021
Q2
$927K Buy
23,684
+94
+0.4% +$3.65K 0.71% 27
2021
Q1
$854K Buy
23,590
+669
+3% +$23.8K 0.72% 27
2020
Q4
$843K Buy
22,921
+296
+1% +$10.9K 0.76% 25
2020
Q3
$787K Buy
22,625
+234
+1% +$8.2K 0.79% 27
2020
Q2
$694K Buy
22,391
+291
+1% +$9.89K 0.73% 32
2020
Q1
$684K Sell
22,100
-89
-0.4% -$3.03K 0.82% 31
2019
Q4
$824K Buy
+22,189
New +$790K 0.79% 42

Other funds holding PFE

Beaumont Asset Management's PFE Position: Q2 2025 in Review

Beaumont Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 17,517 shares — an estimated $444K sold.

Beaumont Asset Management first reported a position in PFE in Q4 2019 and held it in 21 quarters. The position peaked at $1.54M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Beaumont Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Beaumont Asset Management sold 17,517 Pfizer shares in Q2 2025, an estimated $444K.
  • Beaumont Asset Management first reported a position in Pfizer in Q4 2019 and held it in 21 quarters.
  • Beaumont Asset Management's Pfizer position peaked at $1.54M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Beaumont Asset Management's 13F filing for Q2 2025, filed 23 Jul 2025.